Main points:
- do surveillance well
- get your pathologist to do p53 IHC
- Cytopsonge might save on endoscopy. Watch that space! #fgdebate
Rebecca Fitzgerald
Rebecca Clare Fitzgerald (born September 1968) is a British medical researcher who studies cancer evolution to find new ways to detect and prevent cancer, with a particular focus on oesophageal cancer. She is a tenured Professor of Cancer Prevention and is the founding Director at the Early Cancer Institute of the University of Cambridge. More on Wikipedia
-
Rebecca Fitzgerald
@RC_Fitzgerald
-
Rebecca Fitzgerald
@RC_Fitzgerald
-
Rebecca Fitzgerald
@RC_Fitzgerald
Just to emphasize that ablation is for dysplasia and not for everyone. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
This is where the #cytosponge could also be advantageous. Just need to determine biomarkers for surveillance but p53 looks good #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Rebecca Fitzgerald
@RC_Fitzgerald
@IanARowe @FrontGastro_BMJ @IanForgacs Agree. This is still research territory. Clinical surveillance needs careful white light OGD + path
-
Post not available here, view on XPost not available here, view on X
Rebecca Fitzgerald
@RC_Fitzgerald
@IanARowe @FrontGastro_BMJ @IanForgacs Agree. This is still research territory. Clinical surveillance needs careful white light OGD + path
-
Rebecca Fitzgerald
@RC_Fitzgerald
Advanced imaging needs skilled endoscopists to interpret the images, which can have very subtle changes #fgdebate
-
Rebecca Fitzgerald reposted
Frontline Gastro
@FrontGastro_BMJ
@IanForgacs Is this the case of centralisation the Dutch have advocated? #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Great thing about #cytosponge is can use it in primary care, little sampling bias and objective biomarker to diagnose #barretts #fgdebate
-
Rebecca Fitzgerald reposted
Frontline Gastro
@FrontGastro_BMJ
@RC_Fitzgerald @IanForgacs Here is the link to the @BritSocGastro guidelines on this www.bsg.org.uk/clinical-guidelines/oesophageal/guidelines… #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Talk to your pathologist about p53 as an adjunct to diagnosing dysplasia. It is really useful! #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Consensus reporting of dysplasia essential to avoid over diagnosis and over treatment. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Need better ways to objectively risk-stratify #fgdebate @IanARowe
-
Rebecca Fitzgerald
@RC_Fitzgerald
Enough data on increased cancer risk in dysplasia for NICE to recommend ablation therapy. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Endoscopic treatment has massive impact since confirmed dysplasia picked up on surveillance is now treated. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Risk varies with length of #barretts and presence of IM. So should tailor surveillance accordingly #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Some people ask whether given the low conversion rate we should do surveillance? #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
What do you all think? #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Biopsy all visible lesions and use Seattle Protocol (4 biopsies every 2cm). Sampling bias is a real problem. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Surveillance has to be done well i.e. good inspection, lots of biopsies, good pathology. Otherwise, it is a waste of time. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Surveillance of #barretts is part of cancer reduction strategy because of well-defined sequence. #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
Alarming increase in #oesophagealcancer What are we going to do about it? #fgdebate
-
Rebecca Fitzgerald
@RC_Fitzgerald
We're going live in 8minutes! Tweet in your questions! #fgdebate
-
Rebecca Fitzgerald reposted
Frontline Gastro
@FrontGastro_BMJ
Our next #fgdebate is with Prof Fitzgerald @RC_Fitzgerald on 6/10/15 prior to #uegw2015 @my_ueg @BritSocGastro
-
Rebecca Fitzgerald reposted
United European Gastroenterology
@my_ueg
Another chance to pursue this topic is at #uegweek "Women in GI" session, chaired by @RC_fitzgerald uegw.congress-online.com/guest/SciProgramSessionsList?SSN… #fgdebate
-
Rebecca Fitzgerald reposted
Frontline Gastro
@FrontGastro_BMJ
Please join us for the next #fgdebate with Prof Rebecca Fitzgerald @my_ueg 6th October on Barrett's @RC_Fitzgerald
-
Rebecca Fitzgerald reposted
Christian
@chrisferner
@nataliewood06 @RC_Fitzgerald @adartom @RuiCastroHD @puentesfabi Definitely! Really looking forward to :-)
-
Rebecca Fitzgerald
@RC_Fitzgerald
RT @RC_Fitzgerald @adartom @Bjorn_Rembacken Inspirging and encouraging mentors really made a difference too, said keep going,create niche
-
Rebecca Fitzgerald reposted
Natalie Wood
@nataliewood06
Looking forward to the #weekchat @my_ueg @RC_Fitzgerald
-
Rebecca Fitzgerald reposted
United European Gastroenterology
@my_ueg
Hot topics in GI cancer with @RC_Fitzgerald tweet us questions using #weekchat #bowelcancer #crc #oesophagus
-
Rebecca Fitzgerald reposted
United European Gastroenterology
@my_ueg
Chat with Research Prize Awardee @RC_Fitzgerald tomorrow, 17:30. Send your comments using #weekchat
-
Rebecca Fitzgerald reposted
United European Gastroenterology
@my_ueg
@emadelomar @massi_dipietro @PhilW_Gastro join #weekchat with @rc_fitzgerald 'Hot GI Cancer topics' on Oct 21? ueg.eu/news/news/news-details/article/join-the-weekchat-a…
-
Rebecca Fitzgerald reposted
Tomer Adar
@adartom
@my_ueg
Interested in learning why @RC_Fitzgerald is awarded this year's research prize? Don’t miss out on the #weekchat (Oct 21, 17:30) -
Rebecca Fitzgerald
@RC_Fitzgerald
Please join me @RC_Fitzgerald at #weekchat (Oct 21, 17:30) will be fun to why so many opportunities in GI research right now
-
Rebecca Fitzgerald
@RC_Fitzgerald
NEJM had lost of correspondence on this paper.
What do you think? -
Rebecca Fitzgerald
@RC_Fitzgerald
Multi-gene testing detected more cancers compared with FIT but had more fals positives. So is sensitivity or specificty more important?
-
Rebecca Fitzgerald
@RC_Fitzgerald
Really interesting paper on multi-gene DNA test for colorectal cancer screening in NEJM published this year (Imperiale et al NEJM 370;14)











